Day: March 27, 2025

VANCOUVER, British Columbia, March 27, 2025 (GLOBE NEWSWIRE) — Dominion Lending Centres Inc. (TSX:DLCG) (“DLCG” or the “Corporation”) is pleased to report its financial results for the three months (“Q4-2024”) and year ended December 31, 2024 (“annual”). For complete information, readers should refer to the annual audited consolidated financial statements and management discussion and analysis which are dated March 27, 2025 and are available on SEDAR+ at www.sedarplus.ca and on the Corporation’s website at www.dlcg.ca. All amounts are presented in Canadian dollars unless otherwise stated. DLCG includes the Corporation and its three main subsidiaries: MCC Mortgage Centres Canada Inc. (“MCC”), MA Mortgage Architects Inc. (“MA”), and Newton Connectivity Systems Inc. (“Newton”). The Corporation’s acquisition of all of the series I,...

MALVERN, Pa., March 27, 2025 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) is issuing this press release to update the reporting of its financial results for the fourth quarter and full year ending December 31, 2024. Following the Company’s press release on March 4, 2025 initially issuing the Company’s fourth quarter and full year 2024 financial results (the “Initial Release”) and in connection with finalizing the audited financial statements for the fiscal year ending December 31, 2024, certain non-cash revisions were made to the financial statements related to the Company’s acquisition of Greenbrook TMS Inc. (“Greenbrook”) and the shares outstanding in the fourth quarter of 2024. These accounting updates resulted in, among other things: Fourth Quarter 2024 Results for the Three Months Ended...

TEL AVIV, Israel, March 27, 2025 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q1 2025 Aide Memoire is available on the “Investors” page on its website. Q1 2025 Aide Memoire Teva has prepared this document to assist in the financial modeling of its quarterly results. The document is based on Teva’s prior results, management’s previous commentary about Teva’s business outlook and data from select independent sources. Going forward, it is Teva’s intention to provide this information towards the end of each quarter. About Teva Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a different kind of global biopharmaceutical leader, one that operates across the full spectrum of innovation to reliably deliver medicines to patients worldwide. For over 120 years, Teva’s commitment...

CALGARY, Alberta, March 27, 2025 (GLOBE NEWSWIRE) — Global Uranium Corp. (CSE: GURN | OTC: GURFF | FRA: Q3J) (the “Company” or “Global”) announces that it has filed auditor-reviewed amended and restated unaudited interim condensed consolidated financial statements and the associated MD&A for the nine months ended October 31, 2024 (“Reviewed Interim Financial Statements”). The condensed consolidated interim financial statements for the nine months ended October 31, 2024 have been amended as a result of the Company reclassifying advertising and promotion to prepaid expense due to the timing of campaign activities undertaken by Euro Digital Marketing, taking place after October 31, 2024. As a result, $674,405 of advertising and promotion has been reclassified as short-term assets within prepaid expense. A copy of...

Board Approves US$10 million Share Repurchase Program SUZHOU, China, March 28, 2025 (GLOBE NEWSWIRE) — YXT.com Group Holding Limited (NASDAQ: YXT) (“YXT.com” or the “Company”), a provider of AI-enabled enterprise productivity solutions, today announced its unaudited financial results for the full year ended December 31, 2024 and a US$10 million Share Repurchase Program. Financial Highlights for the Full Year of 2024Total revenues were RMB331.2 million (US$45.4 million) for the full year of 2024, compared with RMB424.0 million in the prior year. On the pro forma basis as if the deconsolidation of CEIBS Publishing Group Limited (“CEIBS PG”) occurred as of the beginning of 2022, the pro forma revenues would have been RMB327.9 million (US$44.9 million) for the full year of 2024, compared with RMB324.6 million for the full year of...

CALGARY, Alberta, March 27, 2025 (GLOBE NEWSWIRE) — Inventronics Limited (“Corporation”) (IVX:TSX Venture), a designer and manufacturer of enclosures for the telecommunication, cable, electric distribution, energy, and other industries in North America, today announced its 2024 audited annual and unaudited 2024 Q4 financial results. For the year ended December 31, 2024, the Corporation reported a net loss of $62,000, or 1.3 cents per share, on revenue of $6,309,000 compared to net earnings of $369,000, or 7.6 cents per share, on revenue of $8,859,000 for the 2023 fiscal year. For the three months ended December 31, 2024, the Corporation reported a net loss of $242,000, or 5.0 cents per share, on revenue of $1,304,000 compared to a net loss of $207,000, or 4.2 cents per share, on revenue of $959,000, for the same period in 2023.Income...

2024 Research & Development Revenue of $30 Million Successful Results from the US Burn Validation Study On Track for Regulatory Submission in US for DeepView™ System DALLAS, March 27, 2025 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (“AI”) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced financial results for the fourth quarter (“Q4 2024”) and full year (“FY 2024”) ended December 31, 2024, and provided an update on its ongoing business activities. “Spectral AI achieved much in 2024. Our top-line revenue reflects extensive work on our BARDA PBS contract, and our progress along multiple fronts has continued into 2025,” said Dr. J. Michael DiMaio, M.D., the Company’s Chairman of the...

ORLANDO, Fla., March 27, 2025 (GLOBE NEWSWIRE) — IZEA Worldwide, Inc. (NASDAQ: IZEA), a leading influencer marketing company that makes Creator Economy solutions for marketers, reported its financial and operational results for the fourth quarter and year ended December 31, 2024. Q4 2024 Financial Summary Compared to Q4 2023Total revenue increased 23.7% to $11.0 million, compared to $8.9 million Managed Services bookings increased 52.8% to $11.7 million, compared to $7.6 million Managed Services revenue increased 24.0% to $10.9 million, compared to $8.8 million Total costs and expenses increased 28.0% to $14.2 million, compared to $11.1 million Net loss was $4.6 million, including $2.7 million of one-time charges, compared to a net loss of $1.5 million Adjusted EBITDA* for the quarter was $(1.5) million, compared to $(1.1) million Cash,...